Vacv Biotherapeutics
VacV Biotherapeutics is a cancer immunotherapy company developing innovative viral-based therapies for cancers. Launched in 2022 by cancer immunotherapy pioneers Professor Yaohe Wang, Professor Nicholas Lemoine, Dr. Louisa Chard Dunmall and Dr. Peng Liu, VacV employs a unique approach to immunotherapy based on the Vaccinia virus to stimulate a patient’s immune system to fight cancer while simultaneously destroying cancer cells. This approach offers many advantages over existing immunotherapies, including minimized toxicity, higher specificity and efficacy, allowing for efficient systemic delivery of an immunotherapy for the first time.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Vacv Biotherapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- GE
Glyn Edwards
Executive Chairman · General Business & Management
EmailPhone - RB
Renato Brito Baleeiro
- Ä · Other
EmailPhone
Showing 2 of 7 verified contacts
Top roles at Vacv Biotherapeutics
6 distinct titles indexed · top 6 shown.
- 1- ä
- 1executive assistant office manager
- 1executive chairman
- 1professor of cancer cell and gene therapy, barts cancer institute, queen mary university of london
- 1research scientist
- 1清华大学经济管理学院
Sign up to unlock all 7 contacts at Vacv Biotherapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Vacv Biotherapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.